secwatch.observer — SEC 8-K summary
======================================

Issuer:     PharmaCyte Biotech, Inc. (PMCB)
CIK:        0001157075
Form:       8-K
Filed at:   2022-03-09T23:59:59+00:00
Accession:  0001683168-22-001550
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PharmaCyte Biotech posts corporate presentation on its website; no financial or clinical updates disclosed.
--------------------------------------------------------------------------------

- Company made a corporate presentation available on its website for investor and analyst use.
- Presentation contains standard forward-looking statements and disclaimers; no specific figures or milestones provided.
- No material new information about pipeline, financials, or business developments was disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1157075/000168316822001550/0001683168-22-001550-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1157075/000168316822001550/pharmacyte_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-001550

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer